| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.02 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.41 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.29 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.22 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |